Ryan Williams: This Article Brings to Light The Complexity of PRP…
Ryan Williams, Physician Assistant at BHS Orthopedic Associates, shared on LinkedIn about a recent article by Benjamin B. Rothrauff et al, published in The American Journal of Sports Medicine:
”This article brings to light the complexity of PRP on more than the most popular topic, platelet dose.
The authors highlight patient specific impact, biologic composition, preparation, activation, ability to store PRP for future use, allogenic vs. autologous PRP, EVs, and peri-procedure optimization.
Practically, variables that can be impacted are:
1. Optimize the patient (address comorbidities, nutrition, exercise, sleep, and stress).
2. Have a consistent, high quality PRP protocol.
3. Use safe, quality, and value-based energy (not mentioned in the article), exercise (BFR), pharmaceutical and nutraceutical tools to enhance the patient and the composition of the PRP.
I’m curious of others real-world experience with pre-blood draw exercise and BFR, using a senolytic (dasatinib and quercetin, fisetin, astragalus/TA-65, etc.) or losartan (or any ARB) and any other optimization strategies.
I’ve had some patients inquire about optimizing their PRP with exercise and supplements.
I’ve had several ask about red/NIR light therapy which I encourage them to do before the procedure and continue after if they have already purchased a device (this was not mentioned in the article). ”
Title: Platelet-Rich Plasma in the Treatment of Musculoskeletal Disease in 2025 and Beyond
Authors: Benjamin B. Rothrauff, Joseph T. Featherall, Tyler J. Uppstrom, Greta Gohring, Anna-Laura Nelson, Thos A. Evans, Peter J. Millett, Matthew T. Provencher, Marc J. Philippon, Johnny Huard
Read the Full Article on The American Journal of Sports Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments